TY - JOUR
T1 - Kinin receptors in cultured rat microglia
AU - Noda, Mami
AU - Kariura, Yukihiro
AU - Amano, Taiju
AU - Manago, Yoshimasa
AU - Nishikawa, Kaori
AU - Aoki, Shunsuke
AU - Wada, Keiji
N1 - Funding Information:
We thank Prof. H. Nakanishi (Kyushu University), Prof. N. Akaike (Kyushu University), Prof. D.A. Brown (University College, London), Prof. H. Higashida (Kanazawa University) and Dr. M. Brodwick (University of Texas Medical Branch) for their helpful comments. This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Kyushu University Foundation, and Grants-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan.
PY - 2004/7
Y1 - 2004/7
N2 - Kinins are produced and act at the site of injury and inflammation in various tissues. They are likely to initiate a particular cascade of inflammatory events, which evokes physiological and pathophysiological responses including an increase in blood flow and plasma leakage. In the central nervous system (CNS), kinins are potent stimulators of the production and release of pro-inflammatory mediators represented by prostanoids and cytotoxins. They are known to induce neural tissue damage. Many of the cytotoxins such as cytokines and free radicals and prostanoids are released from glial cells. Among glial cells, astrocytes and oligodendrocytes are known to possess bradykinin (BK) B2 receptors that phosphoinositide (PI) turnover and raise intracellular Ca2+ concentration. The presence of bradykinin receptors in microglia has been of great significance. We recently showed that rat primary microglia express kinin receptors. In resting microglia, B 2 receptors but not B1 receptors are expressed. When the microglia are activated by bradykinin, B1 receptors are up-regulated, while B2 receptors are down-regulated. As observed in other glial cells, electrophysiological measurements suggest that B2 receptors in phosphoinositide turnover and intracellular Ca2+ concentration in microglia. Release of cytotoxins is likely consequent upon the activation of BK receptors. Our study provides the first evidence that microglia express functional kinin receptors and suggests that microglia play an important role in CNS inflammatory responses.
AB - Kinins are produced and act at the site of injury and inflammation in various tissues. They are likely to initiate a particular cascade of inflammatory events, which evokes physiological and pathophysiological responses including an increase in blood flow and plasma leakage. In the central nervous system (CNS), kinins are potent stimulators of the production and release of pro-inflammatory mediators represented by prostanoids and cytotoxins. They are known to induce neural tissue damage. Many of the cytotoxins such as cytokines and free radicals and prostanoids are released from glial cells. Among glial cells, astrocytes and oligodendrocytes are known to possess bradykinin (BK) B2 receptors that phosphoinositide (PI) turnover and raise intracellular Ca2+ concentration. The presence of bradykinin receptors in microglia has been of great significance. We recently showed that rat primary microglia express kinin receptors. In resting microglia, B 2 receptors but not B1 receptors are expressed. When the microglia are activated by bradykinin, B1 receptors are up-regulated, while B2 receptors are down-regulated. As observed in other glial cells, electrophysiological measurements suggest that B2 receptors in phosphoinositide turnover and intracellular Ca2+ concentration in microglia. Release of cytotoxins is likely consequent upon the activation of BK receptors. Our study provides the first evidence that microglia express functional kinin receptors and suggests that microglia play an important role in CNS inflammatory responses.
UR - http://www.scopus.com/inward/record.url?scp=2442461389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442461389&partnerID=8YFLogxK
U2 - 10.1016/j.neuint.2003.07.007
DO - 10.1016/j.neuint.2003.07.007
M3 - Article
C2 - 15145558
AN - SCOPUS:2442461389
SN - 0197-0186
VL - 45
SP - 437
EP - 442
JO - Neurochemistry International
JF - Neurochemistry International
IS - 2-3
ER -